Lorenzo Leggio
speaker
155 appearances
2 recordings
1 series
first heard Feb 2026
last heard 28 Feb
Lorenzo Leggio’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 2 in all, peaking in Feb 2026 with 2.
Appearances
For example, we have actually three medications approved by the FDA for people with alcohol use disorder.
Natrexone, Acamproset, Desofra.
We have two more medications that are called Pyramid and Gabapentin.
Sometimes the people, clinicians use off-label with the consent of the patient.
These medications are endorsed by the American Psychiatric Association as a second-line treatment.
And that's an example of off-label use.
Yeah, you are absolutely right, David.
So we actually, as a society, as a community, as a clinical community, we dramatically undertreat the people with alcohol use disorder.
To give you, to make an analogy,
So in the United States, 2% of people with alcohol disorder receive a prescription for an FDA-approved medication, naltrexone, acamprosate, or disulfiram.
As a comparison, 85% of people with diabetes receive the prescription for a medication approved for diabetes.
It would be unacceptable.
You're absolutely right.
And so what are the reasons?
I mean, there are many reasons.
People tend to be ashamed or not even recognize that their alcohol drinking is problematic.
So many people don't seek treatment.
But also many clinicians are not trained to identify, screen, diagnose, and treat people with alcohol use disorder.
We don't make addiction a foundational part of a medical school and residency.
And then the last but not the least, which also is part of the first two reasons, addictions are highly stigmatized, including alcohol use disorder.
Showing 101–120 of 155 · page 6 of 8
← Previous
Next →